Evidence map›Paper›PMID 22367198›Full record

ArticleThe Journal of biological chemistry2012

Aminoglycoside 2''-phosphotransferase IIIa (APH(2'')-IIIa) prefers GTP over ATP: structural templates for nucleotide recognition in the bacterial aminoglycoside-2'' kinases.

Clyde A Smith, Marta Toth, Hilary Frase, Laura J Byrnes, Sergei B Vakulenko

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance.Frontiers in cellular and infection microbiology · 2013
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Clyde A SmithStanford Synchrotron Radiation Lightsource, Stanford University, Menlo Park, California 94025, USA. csmith@slac.stanford.edu
Marta Toth
Hilary Frase
Laura J Byrnes
Sergei B Vakulenko
University of Notre Dame · USStanford Synchrotron Radiation Lightsource · US

Funding

ZWITTERION SURFACTANT DDMAB FOR IMPROV STABIL OF PROTEINP41RR001209 · NCRR · STANFORD UNIVERSITY · PI GONZALEZ, ANA M · 1985 to 2011
$38.9M
Aminoglycoside Resistance in EnterococcusR01AI057393 · NIAID · UNIVERSITY OF NOTRE DAME · PI VAKULENKO, SERGEI · 2006 to 2015
$3.5M
NCRR NIH HHS 5 P41 RR001209NCRR NIH HHS P41 RR001209NIAID NIH HHS AI057393NIAID NIH HHS R01 AI057393
6 · The paper itself

Abstract

Contrary to the accepted dogma that ATP is the canonical phosphate donor in aminoglycoside kinases and protein kinases, it was recently demonstrated that all members of the bacterial aminoglycoside 2''-phosphotransferase IIIa (APH(2'')) aminoglycoside kinase family are unique in their ability to utilize GTP as a cofactor for antibiotic modification. Here we describe the structural determinants for GTP recognition in these enzymes. The crystal structure of the GTP-dependent APH(2'')-IIIa shows that although this enzyme has templates for both ATP and GTP binding superimposed on a single nucleotide specificity motif, access to the ATP-binding template is blocked by a bulky tyrosine residue. Substitution of this tyrosine by a smaller amino acid opens access to the ATP template. Similar GTP binding templates are conserved in other bacterial aminoglycoside kinases, whereas in the structurally related eukaryotic protein kinases this template is less conserved. The aminoglycoside kinases are important antibiotic resistance enzymes in bacteria, whose wide dissemination severely limits available therapeutic options, and the GTP binding templates could be exploited as new, previously unexplored targets for inhibitors of these clinically important enzymes.

Indexed as

Adenosine TriphosphateAminoglycosidesBacterial ProteinsCrystallographyDrug Resistance, BacterialGuanosine TriphosphatePhosphotransferases (Alcohol Group Acceptor)Protein Serine-Threonine KinasesProtein Structure, SecondaryProtein Structure, TertiaryAdenosine Triphosphateaminoglycoside 2''-phosphotransferaseAminoglycosidesBacterial ProteinsGuanosine TriphosphatePhosphotransferases (Alcohol Group Acceptor)Protein Serine-Threonine Kinases

Identifiers

PMID22367198
PMCPMC3339938
OpenAlexW2064587167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.